BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leculier C, Benzerara O, Couprie N, Francina A, Lasne Y, Archimbaud E, Fiere D. Specific binding between human neutrophils and heparin. Br J Haematol. 1992;81:81-85. [PMID: 1520630 DOI: 10.1111/j.1365-2141.1992.tb08176.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Nourreddine FZ, Oussedik-Oumehdi H, Laraba-Djebari F. Myotoxicity induced by Cerastes cerastes venom: Beneficial effect of heparin in skeletal muscle tissue regeneration. Acta Trop 2020;202:105274. [PMID: 31738878 DOI: 10.1016/j.actatropica.2019.105274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Mulloy B, Hogwood J, Gray E, Lever R, Page CP. Pharmacology of Heparin and Related Drugs. Pharmacol Rev 2016;68:76-141. [PMID: 26672027 DOI: 10.1124/pr.115.011247] [Cited by in Crossref: 149] [Cited by in F6Publishing: 125] [Article Influence: 24.8] [Reference Citation Analysis]
3 Glas GJ, Muller J, Binnekade JM, Cleffken B, Colpaert K, Dixon B, Juffermans NP, Knape P, Levi MM, Loef BG, Mackie DP, Malbrain M, Schultz MJ, van der Sluijs KF. HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial. Trials 2014;15:91. [PMID: 24661817 DOI: 10.1186/1745-6215-15-91] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
4 Różalska B, Ljungh A, Burow A, Rudnicka W. Biomaterial-Associated Infection with Candida albicans in Mice. Microbiology and Immunology 1995;39:443-50. [DOI: 10.1111/j.1348-0421.1995.tb02227.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
5 Page C. Heparin and related drugs: beyond anticoagulant activity. ISRN Pharmacol 2013;2013:910743. [PMID: 23984092 DOI: 10.1155/2013/910743] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
6 Borawski J. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin. Am J Kidney Dis 2006;47:37-41. [PMID: 16377383 DOI: 10.1053/j.ajkd.2005.10.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
7 Dobosz M, Mionskowska L, Hać S, Dobrowolski S, Dymecki D, Wajda Z. Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats. World J Gastroenterol 2004; 10(17): 2553-2556 [PMID: 15300904 DOI: 10.3748/wjg.v10.i17.2553] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
8 Anastase-Ravion S, Blondin C, Cholley B, Haeffner-Cavaillon N, Castellot JJ, Letourneur D. Heparin inhibits lipopolysaccharide (LPS) binding to leukocytes and LPS-induced cytokine production. J Biomed Mater Res A 2003;66:376-84. [PMID: 12889008 DOI: 10.1002/jbm.a.10604] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
9 Videm V. Endpoint-attached heparin blocks neutrophil sticking and spreading. Biomaterials 2004;25:43-51. [DOI: 10.1016/s0142-9612(03)00470-8] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
10 Imai K, Iida T, Takano Y, Uozumi N. Membrane-bound heparin binding proteins from HL-60 cells purified in a two-step affinity chromatography differentially eluted with divalent cations. Journal of Chromatography B 2002;780:1-12. [DOI: 10.1016/s1570-0232(02)00404-x] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Leitienne P, Fouque D, Rigal D, Adeleine P, Trzeciak MC, Laville M. Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept. Nephrol Dial Transplant 2000;15:1631-7. [PMID: 11007833 DOI: 10.1093/ndt/15.10.1631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
12 Young E, Venner T, Ribau J, Shaughnessy S, Hirsh J, Podor TJ. The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells. Thrombosis Research 1999;96:373-81. [DOI: 10.1016/s0049-3848(99)00125-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Erduran E, Tekelio?lu Y, Gedik Y, Y?ld?ran A. Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: Results of a preliminary in vitro study. Am J Hematol 1999;61:90-3. [DOI: 10.1002/(sici)1096-8652(199906)61:2<90::aid-ajh2>3.0.co;2-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
14 Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 1998;101:877-89. [PMID: 9466983 DOI: 10.1172/JCI1509] [Cited by in Crossref: 278] [Cited by in F6Publishing: 89] [Article Influence: 11.6] [Reference Citation Analysis]
15 Bergqvist D, Siegbahn A. Effects of Heparin on the Vessel Wall and Blood Cellular Elements. Vascular Medicine Review 1993;vmr-4:221-33. [DOI: 10.1177/1358863x9300400305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]